Curis Lifesciences IPO
Curis Lifesciences is an NSE SME IPO listed on the NSE SME platform, priced at ₹120–₹128 per share. The stock debuted at ₹146.1, delivering a listing gain of 14.1%. The IPO had a lot size of ₹1000 shares and a minimum investment of ₹2,56,000.
Curis Lifesciences Limited IPO
- IPO Dates
- Nov 7, 2025 – Nov 11, 2025
- Price band
- ₹120-128 per equity share
- Minimum Investment
- ₹2,56,000
- Issue size
- ₹27.52 Cr
- Lot size
- 1000
- Allotment Date
- Nov 12, 2025
- Listing
- Nov 14, 2025
- Listing At
- NSE SME
IPO timeline
-
Nov 7, 2025
Open Date
Completed
-
Nov 11, 2025
Close Date
Completed
-
Nov 12, 2025
Allotment Date
Completed
-
Nov 14, 2025
Listing Date
Completed
Curis Lifesciences IPO Subscription Details
View Subscription DetailsCuris Lifesciences IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Curis Lifesciences IPO Essentials
Curis Lifesciences IPO Details
Curis Lifesciences IPO is priced at ₹120-128 per share with a total issue size of 27.52 crore. The IPO has a lot size of 1000 shares and is listed on NSE SME.
- Issue price
- ₹120-128 per equity share
- Lot size
- 1000 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 21,50,000 shares(aggregating up to ₹27.52 Cr)
- Total issue size
- 21,50,000 shares
(aggregating up to ₹27.52 crore) - Fresh issue
- 21,50,000 shares
(aggregating up to ₹27.52 crore) - Listing at
- NSE SME
- List price
- 146.1
- Listing date
- Registrar
- MUFG Intime India Pvt.Ltd.
- Lead manager
-
Finaax Capital Advisors Private Limited
Market Lot Size
Investors can bid for a minimum of 2000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 2000 | ₹2,56,000 |
| Individual(max) | 2 | 2000 | ₹2,56,000 |
| sHNI(min) | 3 | 3000 | ₹3,84,000 |
| sHNI(max) | 7 | 7000 | ₹8,96,000 |
| sHNI(min) | 8 | 8000 | ₹10,24,000 |
Curis Lifesciences IPO Reservation
Curis Lifesciences IPO reservation details show category-wise allocation of shares. Out of the total 2150000 shares, approximately 19.02% are reserved for QIB, 14.33% for NII, 33.3% for retail investors, 5.02% for market maker, and 28.33% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 609000 (28.33%) | |
| Market Maker Shares Offered | 108000 (5.02%) | |
| QIB Shares Offered | 409000 (19.02%) | |
| NII (HNI) Shares Offered | 308000 (14.33%) | |
| bHNI > ₹10L | 206000 (10%) | 69 |
| sHNI < ₹10L | 102000 (5%) | 34 |
| Individual Shares Offered | 716000 (33.3%) | 358 |
| Total Shares Offered | 2150000 (100%) |
Curis Lifesciences IPO Analytics
Curis Lifesciences IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Curis Lifesciences IPO Subscription Status
Curis Lifesciences IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 74.47x, indicating strong demand across investor categories.
| As on | QIB / NII | Individual | Total |
|---|---|---|---|
| Shares Offered / Reserved | 4,09,000 / 3,08,000 | 7,16,000 | 14,33,000 |
|
Day 1
07-11-25 06:00 PM
|
(8.34 / 1.19) x | 0.87 x | 3.07 x |
|
Day 2
10-11-25 06:00 PM
|
(8.34 / 4.06) x | 3.80 x | 5.15 x |
|
Day 3
11-11-25 06:00 PM
|
(96.17 / 115.81) x | 44.28 x | 74.47 x |
|
Total No. of Applications
|
bHNI | sHNI | Individual |
|---|---|---|---|
| 21473 (Approx) | 52.25x | 57.97x | 44.28x |
Curis Lifesciences Valuations
Earnings
- EPS Pre IPO
- ₹10.29/-
- EPS Post IPO
- ₹10.66/-
- P/E Pre IPO
- 12.44
- P/E Post IPO
- 12.01
Returns
- ROE
- 55.25%
- ROCE
- 27.83%
- RoNW
- 37.62%
- PAT Margin
- 12.43%
Fundamentals
- Debt / Equity
- 0.96
- Price / Book
- 12.64
- Market Cap
- 103.48 Cr.
Curis Lifesciences Financials( In Crs.)
| 31-Dec-24 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|---|
| Assets | 50.12 | 33.82 | 29.67 | 27.40 |
| Revenue | 36.91 | 35.89 | 36.39 | 23.76 |
| Profit After Tax | 5.30 | 5.03 | 1.85 | 0.49 |
| Net Worth | 15.53 | 5.97 | 0.95 | 0.90 |
| Reserves & Surplus | 9.59 | 5.47 | 0.45 | -1.40 |
| Total Borrowing | 16.16 | 17.09 | 16.19 | 17.62 |
Curis Lifesciences Company & Offer Insights
About Curis Lifesciences
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products.
The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.
Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include:
General pharmaceutical tablets and capsules
Oral liquids
External preparations
Sterile ophthalmic ointments
The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Curis Lifesciences Promoter(s)
Mr. Dharmesh Dashrathbhai Patel, Mr. Siddhant Jayantibhai Pawasia, Mr. Piyush Gordhanbhai Antala, Mr. Jaimik Mansukhbhai Patel are the company's promoters of Curis Lifesciences.
Curis Lifesciences IPO Issue Objectives
- •
- Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities
- •
- Capital Expenditure towards Construction of a Storage Facility
- •
- Pre-payment/Repayment of outstanding Secured Loans
- •
- Product Registrations in other countries
- •
- Funding our Working Capital Requirements
- •
- General Corporate Purposes
Contact Information
Contact Details
Curis Lifesciences
+91 99045 22543
PF-23, GIDC Sanand - II, Industrial Estate, Sanand, Ahmedabad, Gujarat, 382110
Registrar Contact Details
MUFG Intime India Private Limited (Link Intime)
+91-22-4918 6270
Frequently Asked Questions
Click any question to reveal the answer
Curis Lifesciences IPO is a book-built IPO worth ₹27.52 crore. The price band is ₹120–₹128 per share. The IPO opens on Nov 7, 2025 and closes on Nov 11, 2025. It will be listed on NSE SME Platform. MUFG Intime India Pvt. Ltd. is the registrar.
The price band of Curis Lifesciences IPO is ₹120 to ₹128 per share.
The lot size of Curis Lifesciences IPO is 1000 shares.
The minimum investment for Curis Lifesciences IPO is approximately ₹2,56,000 based on the upper price band .
Curis Lifesciences IPO opens on Nov 7, 2025 and closes on Nov 11, 2025.
The allotment date of Curis Lifesciences IPO is Nov 12, 2025.
Curis Lifesciences IPO is expected to be listed on Nov 14, 2025, on NSE SME Platform.
Curis Lifesciences IPO valuation snapshot: P/E 12.01, EPS ₹10.66/-, P/B 12.64, RoNW 37.62%, and market cap 103.48 Cr.
To apply for Curis Lifesciences IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Curis Lifesciences IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Curis Lifesciences IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Curis Lifesciences IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Curis Lifesciences IPO allotment status on IPO Ji for quick and easy access.